Reproductive Health Program in Patients With Cancer
NCT01806129 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 434
Last updated 2025-06-13
Summary
This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.
Conditions
- Malignant Neoplasm
Interventions
- OTHER
-
Standard practice related to reproductive heath
Patients undergo usual standard practice related to reproductive health.
- OTHER
-
Training modules, algorithm, referral development
Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
ECOG-ACRIN Cancer Research Group
lead NETWORK
Principal Investigators
-
Ashlesha Patel · Eastern Cooperative Oncology Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-02
- Primary Completion
- 2021-07-31
- Completion
- 2025-12-30
Countries
- United States
Study Locations
More Related Trials
-
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
NCT00030485 ·Status: COMPLETED ·Phase: PHASE2
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Reproductive Health Survivorship Care Plan
NCT02667626 ·Status: COMPLETED ·Phase: NA
-
Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry
NCT01843140 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
NCT05705505 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT02283658 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
NCT05548296 ·Status: RECRUITING ·Phase: PHASE2
-
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
NCT03206450 ·Status: COMPLETED
-
Letrozole in Patients With Ovarian Tumors
NCT00505661 ·Status: TERMINATED ·Phase: PHASE2
-
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00958698 ·Status: UNKNOWN ·Phase: NA
-
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT05287451 ·Status: RECRUITING ·Phase: NA
-
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
NCT00987649 ·Status: COMPLETED
-
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NCT04251052 ·Status: RECRUITING ·Phase: NA
-
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
NCT05603910 ·Status: RECRUITING ·Phase: PHASE1
-
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
NCT01074398 ·Status: UNKNOWN
-
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
NCT05256225 ·Status: RECRUITING ·Phase: PHASE3
-
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
NCT05704621 ·Status: RECRUITING ·Phase: PHASE2
-
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
NCT00331760 ·Status: COMPLETED ·Phase: PHASE2
-
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
NCT05206890 ·Status: RECRUITING
-
New Biomarkers Evaluating Ovarian Cancer
NCT01466049 ·Status: COMPLETED
-
Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
NCT06360471 ·Status: RECRUITING
-
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
NCT05276973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
NCT01579812 ·Status: COMPLETED ·Phase: PHASE2
-
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT05731661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00053833 ·Status: TERMINATED ·Phase: PHASE2